CAR.70-engineered IL-15-transduced cord blood-derived NK cells

CAR-NK cells with IL-15 transduction (cord blood-derived) · MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR.70-engineered IL-15-transduced cord blood-derived NK cells, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma [Phase 1, Phase 2]

See pricing